464 related articles for article (PubMed ID: 27818386)
21. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
[TBL] [Abstract][Full Text] [Related]
22. More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
Tiniakou E; Pinal-Fernandez I; Lloyd TE; Albayda J; Paik J; Werner JL; Parks CA; Casciola-Rosen L; Christopher-Stine L; Mammen AL
Rheumatology (Oxford); 2017 May; 56(5):787-794. PubMed ID: 28096458
[TBL] [Abstract][Full Text] [Related]
23. Spectrum of immune-mediated necrotizing myopathies and their treatments.
Pinal-Fernandez I; Mammen AL
Curr Opin Rheumatol; 2016 Nov; 28(6):619-24. PubMed ID: 27607340
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous involvement in anti-HMGCR positive necrotizing myopathy.
Williams B; Horn MP; Banz Y; Feldmeyer L; Villiger PM
J Autoimmun; 2021 Sep; 123():102691. PubMed ID: 34332436
[TBL] [Abstract][Full Text] [Related]
25. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy.
Limaye V; Bundell C; Hollingsworth P; Rojana-Udomsart A; Mastaglia F; Blumbergs P; Lester S
Muscle Nerve; 2015 Aug; 52(2):196-203. PubMed ID: 25521389
[TBL] [Abstract][Full Text] [Related]
26. Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy.
Anquetil C; Boyer O; Wesner N; Benveniste O; Allenbach Y
Autoimmun Rev; 2019 Mar; 18(3):223-230. PubMed ID: 30639649
[TBL] [Abstract][Full Text] [Related]
27. Anti-HMGCR Myopathy.
Mohassel P; Mammen AL
J Neuromuscul Dis; 2018; 5(1):11-20. PubMed ID: 29480216
[TBL] [Abstract][Full Text] [Related]
28. Analysis of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase using different technologies.
Musset L; Miyara M; Benveniste O; Charuel JL; Shikhman A; Boyer O; Fowler R; Mammen A; Phillips J; Mahler M
J Immunol Res; 2014; 2014():405956. PubMed ID: 24741598
[TBL] [Abstract][Full Text] [Related]
29. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
[TBL] [Abstract][Full Text] [Related]
30. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.
Ladislau L; Arouche-Delaperche L; Allenbach Y; Benveniste O
Curr Rheumatol Rep; 2018 Aug; 20(9):56. PubMed ID: 30074107
[TBL] [Abstract][Full Text] [Related]
31. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.
Shovman O; Gilburd B; Chayat C; Lazar AD; Amital H; Blank M; Bentow C; Mahler M; Shoenfeld Y
Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830
[TBL] [Abstract][Full Text] [Related]
32. Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies: incidence using different testing criteria, and case series.
Joseph VMK; Rose EC; Edwards CJ; Lloyd M; Amar SK; Wheeler RD; Forster T; Smith KA; Eren E; Hughes R; Hajela V; Kiely PDW
Clin Exp Rheumatol; 2022 Feb; 40(2):298-303. PubMed ID: 35200125
[TBL] [Abstract][Full Text] [Related]
33. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
Werner JL; Christopher-Stine L; Ghazarian SR; Pak KS; Kus JE; Daya NR; Lloyd TE; Mammen AL
Arthritis Rheum; 2012 Dec; 64(12):4087-93. PubMed ID: 22933019
[TBL] [Abstract][Full Text] [Related]
34. [Immune-Mediated Necrotizing Myopathy].
Uruha A
Brain Nerve; 2024 May; 76(5):646-654. PubMed ID: 38741508
[TBL] [Abstract][Full Text] [Related]
35. Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations.
Selva-O'Callaghan A; Alvarado-Cardenas M; Pinal-Fernández I; Trallero-Araguás E; Milisenda JC; Martínez MÁ; Marín A; Labrador-Horrillo M; Juárez C; Grau-Junyent JM
Expert Rev Clin Immunol; 2018 Mar; 14(3):215-224. PubMed ID: 29473763
[TBL] [Abstract][Full Text] [Related]
36. Rituximab in the Treatment of Refractory Anti-HMGCR Immune-mediated Necrotizing Myopathy.
Landon-Cardinal O; Allenbach Y; Soulages A; Rigolet A; Hervier B; Champtiaux N; Monzani Q; Solé G; Benveniste O
J Rheumatol; 2019 Jun; 46(6):623-627. PubMed ID: 30554155
[TBL] [Abstract][Full Text] [Related]
37. Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience.
Klein M; Mann H; Pleštilová L; Zámečník J; Betteridge Z; McHugh N; Vencovský J
Rheumatology (Oxford); 2015 Nov; 54(11):2010-4. PubMed ID: 26109604
[TBL] [Abstract][Full Text] [Related]
38. [A 81-year old man of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody-positive myopathy associated with lung adenocarcinoma cancer].
Yamanaka N; Sato R; Oishi M; Shimizu F; Koga M; Hoshii Y; Kanda T
Rinsho Shinkeigaku; 2021 Jul; 61(7):456-460. PubMed ID: 34148931
[TBL] [Abstract][Full Text] [Related]
39. Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum".
Hamann PD; Cooper RG; McHugh NJ; Chinoy H
Autoimmun Rev; 2013 Oct; 12(12):1177-81. PubMed ID: 23851103
[TBL] [Abstract][Full Text] [Related]
40. Treatment experience of Taiwanese patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase myopathy.
Liang WC; Wang CH; Chen WZ; Kuo YT; Lin HF; Suzuki S; Nishino I; Jong YJ
Kaohsiung J Med Sci; 2020 Aug; 36(8):649-655. PubMed ID: 32666706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
